Myasthenia gravis constitutes chronic autoimmune disease that primarily targets the neuromuscular junction. This junction mediates the transmission of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system incorrectly attacks these receptors, resulting weakness and fatigue in the skeletal tissues. The sym